Vesugen Research for Cardiovascular Health
An evidence-based overview of research examining Vesugen in the context of cardiovascular health. This page synthesizes findings from peer-reviewed literature.
Research Summary
Vesugen is marketed for cardiovascular support based on claimed effects on vascular endothelium gene expression. Russian in-vitro research reports normalization of endothelin-1 and reduced E-selectin expression in cultured endothelium. No animal or human clinical studies of KED in cardiovascular outcomes exist.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Vesugen has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.